Dutch Biotech takes RSV vaccine nasal spray vaccine into Ph I trial
Mucosis B.V. has started a volunteer study of SynGEM, a respiratory syncytial virus (RSV) vaccine formulated for nasal delivery.
Mucosis B.V. has started a volunteer study of SynGEM, a respiratory syncytial virus (RSV) vaccine formulated for nasal delivery.
CiToxLAB has acquired AccelLAB, a preclinical medical device contract research organization (CRO) as the industry works to align the development of new drugs and medical devices.
The USP has proposed monograph for hypromellose capsule shells used to make vegetarian friendly medicines.
EAG Laboratories has set up an elemental impurities lab in response to US FDA moves to align testing rules with ICH Q3D guidance and USP requirements.
Adents and Microsoft have introduced a new platform that allows contract manufacturing organizations (CMOs) to leverage data generated during the serialization process.